We would like to make ismp aware of a supply error that has occurred in our facility on two occasions now.Our pharmacy routinely orders 20% intralipid solutions [fresenius (b)(4)] through our central supply system and they are delivered to the pharmacy in blue totes.On (b)(6) 2018, our pharmacy received a tote of intralipids that also contained a bag of viper slide lubricant[csi] mixed in with the intralipid bags.Viper slide lubricant is indicated for use with csi orbital atherectomy systems.You can see from the attached pictures that these products look extremely similar both in fluid consistency (white liquid) and packaging.The viper slide lubricant bag was not initially noticed by our pharmacy technician and was stocked, unknowingly, in our iv room along with the other intralipids from that tote.Thankfully, one of our pharmacists noticed the lubricant error when they went to pull it for medication preparation.Then, last week, a pharmacist found another bag of lubricant mixed in with our intralipid order.We have communicated these errors to our central supply group and they are investigating how these lubricant bags are ending up in our intralipid supply.Csi should change their packaging to ensure it cannot be confused with other intralipid solutions.Medication administered to or used by the patient: no; where did the error occur: hospital; level of staff who discovered the error: pharmacist.(b)(6); access number: (b)(4).
|